Alchemia Oncology Report issue

For profit Phase 3
Founded: Eight Mile Plains United States (1995)
Status: Acquired by Panther Biotechnology (2015)

Organization Overview

First Clinical Trial
2011
NCT01290783
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

irinotecan (Camptosar) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1